Transaction DateRecipientSharesTypePriceValue
28th August 2020Richard T Schumacher190Other acquisition or disposition$2.32$440.80
28th August 2020Kevin Pollack443Other acquisition or disposition$2.32$1,027.76
28th August 2020Jeffrey N Peterson829Other acquisition or disposition$2.32$1,923.28
28th August 2020Michael S Urdea436Other acquisition or disposition$2.32$1,011.52
28th August 2020Vito J Mangiardi95Other acquisition or disposition$2.32$220.40
8th June 2020Richard T Schumacher210Other acquisition or disposition$2.45$514.50
8th June 2020Vito J Mangiardi105Other acquisition or disposition$2.45$257.25
8th June 2020Jeffrey N Peterson918Other acquisition or disposition$2.45$2,249.10
8th June 2020Kevin Pollack490Other acquisition or disposition$2.45$1,200.50
8th June 2020Michael S Urdea483Other acquisition or disposition$2.45$1,183.35
Pressure Bio Sciences
Pressure Bio Sciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Pressure BioSciences, Inc. is engagedin the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. Its products includes high pressure barocyclers and barozyme, high pressure generators and accessories. The company was founded by Richard Schumacher in August 1978 and is headquartered in South Easton, MA.

Ticker: PBIO
Sector: Health Services
Industry: Services to the Health Industry
SEC Central Index Key (CIK): 830656
Employees: 14
Exchange: US OTC
Auditor Opinion:

Disclosure Language changes
Red Flags